Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.

Cardiovascular diabetology - 2 May 2007

Lebherz Corinna, Sanmiguel Julio, Wilson James M, Rader Daniel J

Abstract excerpt

BACKGROUND: The atheroprotective effects of systemic delivery of either apolipoprotein A-I (wtApoA-I) or the naturally occurring mutant ApoA-I Milano (ApoA-IM) have been established in animal and human trials, but direct comparison studies evaluating the phenotype of ApoA-I or ApoAI-Milano knock-...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Atherosclerosis
Share to Genetic Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypercholesterolemia

Share to Mice, Knockout

Share to Mice, Transgenic

Share to Receptors, LDL

Share to Transduction, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 17475009
DOI: 10.1186/1475-2840-6-15
PMCID: PMC1868709

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17475009-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.PMID 17475009Read ↗

Comparative Effects of Diet-Induced Lipid Lowering Versus Lipid Lowering Along With Apo A-I Milano Gene Therapy on Regression of Atherosclerosis.Semantic proximity Read ↗

Bone Marrow Transplantation Shows Superior Atheroprotective Effects of Gene Therapy With Apolipoprotein A-I Milano Compared With Wild-Type Apolipoprotein A-I in Hyperlipidemic MiceSemantic proximity Read ↗

Gene therapy with novel adeno‐associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemiaSemantic proximity Read ↗

Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of AtherosclerosisSemantic proximity Read ↗

Apolipoprotein A-I(Milano): current perspectives.Semantic proximity Read ↗

Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano.Semantic proximity Read ↗

Apolipoprotein A-I and the molecular variant apoA-I(Milano): evaluation of the antiatherogenic effects in knock-in mouse model.Semantic proximity Read ↗

Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano).Semantic proximity Read ↗

Gene Therapy for Familial HypercholesterolemiaSemantic proximity Read ↗

AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency.Semantic proximity Read ↗

Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis ResearchSemantic proximity Read ↗

Adeno-Associated Virus Serotype 8 Gene Therapy Leads to Significant Lowering of Plasma Cholesterol Levels in Humanized Mouse Models of Homozygous and Heterozygous Familial HypercholesterolemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.